How drug cases are usually organized
Claims about a prescription drug's safety often involve many people who took the same product, so federal courts frequently gather them into multidistrict litigation before a single judge for pretrial proceedings. New York state courts have their own procedures for coordinating mass tort cases. Each person's case still depends on individual facts, such as which drug was taken, for how long, and what injury followed. Being part of a coordinated proceeding does not mean every case is resolved the same way. Advertising about a drug is not evidence that any particular person's injury was caused by it.
Brand, generic, and federal law
Whether a claim can proceed often depends on who made the product a person actually took. Because federal law requires a generic drug's label to match the brand-name label, failure-to-warn claims against generic manufacturers are significantly limited. Claims about the brand-name label raise their own questions about what the manufacturer knew and what it could have changed. Pharmacy dispensing records are often the clearest way to establish the manufacturer, since a pill bottle may not say. Getting those records early is a practical first step, because pharmacies do not keep them indefinitely and switching between manufacturers is common for generics.
What a first review looks at
We ask about the medication, the prescribing and dispensing history, the diagnosis of the injury, and when you first connected the two, because in some situations the filing deadline runs from that discovery. Records from the prescribing physician and from the physicians who treated the injury are both needed. We also ask about other medications and conditions, since causation is usually the central dispute. Pharmaceutical litigation also covers disputes between companies, such as patent cases over generic entry, and those follow a very different path. We explain which kind of matter yours appears to be and what the next steps would involve.
